Genetic factors: Emerging research suggests that genetic variations in GLP-1 receptor function may influence how well individuals respond to these medications, though this area needs more study
Vial sizes vary (5mg, 10mg, 15mg, 20mg, 30mg), pricing structures differ, and promotional discounts muddy direct comparison
The drug has been tested as a once-monthly treatment, as well as with dosing intervals of every other month and once every three months
Lixisenatide Lixisenatide is another GLP-1 receptor agonist with more limited current use in the United States
Whilst Wegovy does not add to infection risk, any signs of infectionfever, persistent cough, unexplained weight loss beyond expected, night sweatsshould prompt immediate medical review